| Identification |
| Name: | N-BUTYLDEOXYNOJIRIMYCIN, HYDROCHLORIDE |
| Synonyms: | N-BUTYLDEOXYNOJIRIMYCIN HCL;N-BUTYLDEOXYNOJIRIMYCIN, HYDROCHLORIDE;N-BUTYL-DNJ, HCL;NB-DNJ, HCL;N-(N-BUTYL)DEOXYNOJIRIMYCIN, HYDROCHLORIDE;Miglustat, Hydrochloride;(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)-,3,4,5-Piperidinetriol Hydrochloride |
| CAS: | 210110-90-0 |
| Molecular Formula: | C10H22ClNO4 |
| Molecular Weight: | 255.74 |
| InChI: | InChI=1/C10H21NO4.ClH/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12;/h7-10,12-15H,2-6H2,1H3;1H/t7-,8+,9-,10+;/m1./s1 |
| Molecular Structure: |
 |
| Properties |
| Flash Point: | 208.5°C |
| Boiling Point: | 421.2°C at 760 mmHg |
| Flash Point: | 208.5°C |
| Usage: | An inhibitor of a-glucosidase 1 as well as being an inhibitor of HIV cytopathicity. N-Butyldeoxynojirimycin has recently been used to retard lipid storage in the central nervous system of an animal model of Tay-Sachs disease.
1-Deoxynojirimycin derivativ |
| Safety Data |
| |
 |
